Administration study for Epoetin Beta Pegol product to healthy Japanese adult males

Not Applicable

• Conditions: ot applicable

• Registration Number: JPRN-jRCT1080221926
• Lead Sponsor: Mitsubishi chemical Medience Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-09-25
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: Male
• Target Recruitment: 3

Inclusion Criteria

Weight: more than 50 kg, BMI :more than 17.6 and below 26.4

Exclusion Criteria

1. Hypersensitivity to drugs,
2. Polychemia (hemoglobin 16 microgram per dL or more),
3. A history of alcoholism or drug addiction,
4. Ethical or OTC pharmaceuticals administered within two weeks before scheduled administration of the study drug,
5. Supplement, grapefruit or its products, or foods containing Hypericum perforatum consumed within one week before scheduled administration of the study drug,
6. Not less than 200 mL of blood is collected within 30 days or not less than 400 mL of blood is collected within 90 days before scheduled administration of the study drug.

Study & Design

• Study Type: Interventional
• Study Design: Not specified